Atlas Trials

Chronic Myeloproliferative Disorders

129 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Chronic Myeloproliferative Disorders

RecordFirmDate
Study of Pulmonary Hypertension in Patients With Chronic Myeloproliferative Disorders at Sohag University Hospital (NCT04843475)Sohag University2021-05-01
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies (NCT02556931)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2015-12-01
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease (NCT00448201)UNC Lineberger Comprehensive Cancer Center2011-01-07
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease (NCT01164163)Children's Oncology Group2010-09-01
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation (NCT01116232)Barbara Ann Karmanos Cancer Institute2010-08-01
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome (NCT00946283)Rutgers, The State University of New Jersey2010-03-01
Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant (NCT01077440)Vanderbilt University2010-02-01
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer (NCT00935090)Barbara Ann Karmanos Cancer Institute2009-09-01
Registry of Older Patients With Cancer (NCT01137825)UNC Lineberger Comprehensive Cancer Center2009-09-01
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer (NCT01137643)UNC Lineberger Comprehensive Cancer Center2009-07-01
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer (NCT00726830)M.D. Anderson Cancer Center2009-03-01
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer (NCT00823524)Asan Medical Center2009-01-01
Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment (NCT00800150)City of Hope Medical Center2008-11-01
Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers (NCT00952185)City of Hope Medical Center2008-11-01
American Ginseng in Treating Patients With Fatigue Caused by Cancer (NCT00719563)Alliance for Clinical Trials in Oncology2008-10-01
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder (NCT00755040)Vanderbilt-Ingram Cancer Center2008-10-01
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer (NCT00816413)University of Nebraska2008-09-01
Blood Samples From Patients on a Clinical Trial to CINV During HSCT (NCT00900068)OHSU Knight Cancer Institute2008-08-01
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases (NCT00813501)City of Hope Medical Center2008-06-01
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families (NCT00782145)Tufts Medical Center2008-06-01
Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers (NCT00770419)Rutgers, The State University of New Jersey2008-05-01
CC-4047 in Treating Patients With Myelofibrosis (NCT00669578)Mayo Clinic2008-05-01
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial (NCT00750009)Case Comprehensive Cancer Center2008-04-01
Low-Dose Decitabine in Treating Patients With Symptomatic Myelofibrosis (NCT00630994)Mayo Clinic2008-03-01
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer (NCT00516503)Alliance for Clinical Trials in Oncology2008-02-01
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant (NCT00513474)Massachusetts General Hospital2008-01-01
Studying Fentanyl in Patients With Cancer (NCT00899951)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2007-10-01
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer (NCT00589563)City of Hope Medical Center2007-05-01
Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer (NCT00806767)Institut Paoli-Calmettes2007-03-01
Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases (NCT00438958)The Canadian Blood and Marrow Transplant Group2007-03-01
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders (NCT00433862)National Institutes of Health Clinical Center (CC)2007-02-06
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases (NCT00453206)Wake Forest University Health Sciences2007-02-01
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases (NCT00424242)Northwestern University2007-01-01
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant (NCT00900406)Vanderbilt-Ingram Cancer Center2007-01-01
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant (NCT00964821)City of Hope Medical Center2007-01-01
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant (NCT00651716)Vanderbilt-Ingram Cancer Center2006-12-01
Azacitidine in Treating Patients With Myelofibrosis (NCT00381693)Mayo Clinic2006-08-01
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant (NCT00410657)Fred Hutchinson Cancer Center2006-07-01
Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases (NCT00376922)Wake Forest University Health Sciences2006-06-01
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis (NCT00132015)National Institutes of Health Clinical Center (CC)2006-05-01
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant (NCT00324324)OHSU Knight Cancer Institute2006-05-01
Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer (NCT00346359)Fred Hutchinson Cancer Center2006-03-01
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant (NCT00281814)The Cleveland Clinic2006-02-01
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation (NCT00281801)Case Comprehensive Cancer Center2006-02-01
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer (NCT00281879)OHSU Knight Cancer Institute2006-02-01
Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders (NCT00293410)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2005-11-01
Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen (NCT00448357)UNC Lineberger Comprehensive Cancer Center2005-10-01
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder (NCT00274820)Case Comprehensive Cancer Center2005-10-01
Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders (NCT00437086)Mayo Clinic2005-09-01
A Standardized Nursing Intervention Protocol for HCT Patients (NCT00951626)City of Hope Medical Center2005-09-01
Imatinib Mesylate in Treating Patients With Myelofibrosis (NCT00245128)OHSU Knight Cancer Institute2005-08-01
Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00245037)OHSU Knight Cancer Institute2005-06-01
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain (NCT00666211)Vanderbilt-Ingram Cancer Center2005-05-01
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia (NCT00295997)University of California, San Francisco2005-05-01
Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders (NCT00114257)National Cancer Institute (NCI)2005-05-01
Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer (NCT00104975)Yale University2005-02-01
Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer (NCT00104923)California Cancer Consortium2005-02-01
Campath-1H + FK506 and Methylprednisolone for GVHD (NCT00109993)Case Comprehensive Cancer Center2005-01-01
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer (NCT00134004)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2004-10-01
Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia (NCT00445900)Mayo Clinic2004-10-01
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant (NCT00293384)Barbara Ann Karmanos Cancer Institute2004-10-01
Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00096096)Fred Hutchinson Cancer Center2004-08-01
Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer (NCT00134017)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2004-06-01
G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders (NCT00253552)OHSU Knight Cancer Institute2004-05-01
Collecting and Storing Blood Samples From Patients With Cancer (NCT00900120)University of Medicine and Dentistry of New Jersey2004-03-01
T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies (NCT00080925)National Institutes of Health Clinical Center (CC)2004-02-01
T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases (NCT00589602)The Cleveland Clinic2004-01-01
Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer (NCT00255684)University of Rochester2003-12-01
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation (NCT00064311)National Institutes of Health Clinical Center (CC)2003-06-01
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies (NCT00068523)Case Comprehensive Cancer Center2003-06-01
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00089037)Fred Hutchinson Cancer Center2003-06-01
Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder (NCT00054340)Fred Hutchinson Cancer Center2002-10-01
Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer (NCT00255710)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2002-07-01
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia (NCT00053157)Roswell Park Cancer Institute2002-06-01
Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia (NCT00054236)Case Comprehensive Cancer Center2002-05-01
Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer (NCT00062231)European Organisation for Research and Treatment of Cancer - EORTC2002-04-01
Pyroxamide in Treating Patients With Advanced Cancer (NCT00042900)Memorial Sloan Kettering Cancer Center2002-04-01
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer (NCT00036790)University of Wisconsin, Madison2002-02-01
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders (NCT00053989)Roswell Park Cancer Institute2002-01-29
Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder (NCT00049634)Fred Hutchinson Cancer Center2002-01-01
Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00301912)University of California, San Francisco2002-01-01
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation (NCT00036712)Medical College of Wisconsin2002-01-01
Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML (NCT00069992)Baylor College of Medicine2001-12-01
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders (NCT00544115)City of Hope Medical Center2001-10-16
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer (NCT00290641)Masonic Cancer Center, University of Minnesota2001-04-01
Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation (NCT00014482)Memorial Sloan Kettering Cancer Center2000-12-01
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment (NCT00006348)Alliance for Clinical Trials in Oncology2000-10-01
Tipifarnib in Treating Patients With Advanced Hematologic Cancer (NCT00005967)National Cancer Institute (NCI)2000-08-01
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon (NCT00010283)Fred Hutchinson Cancer Center2000-07-01
Non-Ablative Allo HSCT For Hematologic Malignancies or SAA (NCT00006379)Case Comprehensive Cancer Center2000-06-01
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis (NCT00006367)Fred Hutchinson Cancer Center2000-05-01
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter (NCT00006083)Jonsson Comprehensive Cancer Center2000-04-01
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant (NCT00716911)City of Hope Medical Center2000-01-01
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment (NCT00004239)Alliance for Clinical Trials in Oncology1999-12-01
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer (NCT00005805)Memorial Sloan Kettering Cancer Center1999-12-01
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer (NCT00004258)Indiana University1999-12-01
Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00004232)Northwestern University1999-10-01
Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia (NCT00004181)Northwestern University1999-10-01
Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00004904)Northwestern University1999-10-01
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00005804)Fred Hutchinson Cancer Center1999-10-01
Next →

Track Chronic Myeloproliferative Disorders automatically

Every clearance here is in the API, with alerts when new ones post.